Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | +5.50% | +9.90% | +4.46% |
13/03 | Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Earnings Flash (AADI) AADI BIOSCIENCE Posts Q4 Revenue $6.3M | MT |
Sales 2024 * | 28.24M 2.36B | Sales 2025 * | 31.81M 2.66B | Capitalization | 51.81M 4.32B |
---|---|---|---|---|---|
Net income 2024 * | -68M -5.68B | Net income 2025 * | -85M -7.1B | EV / Sales 2024 * | 1.83 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.63 x |
P/E ratio 2024 * |
-0.85
x | P/E ratio 2025 * |
-0.73
x | Employees | 89 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.5% |
Latest transcript on Aadi Bioscience, Inc.
1 day | +5.50% | ||
1 week | +9.90% | ||
Current month | +9.90% | ||
1 month | -0.94% | ||
3 months | +20.57% | ||
6 months | -56.22% | ||
Current year | +4.46% |
Managers | Title | Age | Since |
---|---|---|---|
David Lennon
CEO | Chief Executive Officer | 53 | 02/23/02 |
Scott Giacobello
DFI | Director of Finance/CFO | 54 | 28/21/28 |
Neil Desai
CHM | Chairman | 59 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anupam Dalal
BRD | Director/Board Member | 52 | 26/21/26 |
Caley Castelein
CHM | Chairman | 53 | 26/21/26 |
Director/Board Member | 52 | 26/21/26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +8.42% | - |
Date | Price | Change | Volume |
---|---|---|---|
07/24/07 | 2.11 | +5.50% | 129,617 |
06/24/06 | 2 | -5.66% | 167,078 |
03/24/03 | 2.12 | +4.95% | 95,583 |
02/24/02 | 2.02 | +4.12% | 150,680 |
01/24/01 | 1.94 | +1.04% | 186,424 |
Delayed Quote Nasdaq, May 08, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.46% | 51.81M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+54.44% | 24.52B | |
-14.35% | 15.68B | |
-39.65% | 12.23B | |
-6.52% | 12.34B | |
-13.41% | 12.21B | |
+6.22% | 8.83B |
- Stock Market
- Equities
- AADI Stock